Paroxetine: all 122 studies that test it
Page 1 of 2. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Antidepressant Therapy for Improved Blood Vessel Health After PreeclampsiaRecruitingNCT07715669Early Phase 1
- Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus MonotherapyNot yet recruitingNCT07057011Not applicable
- The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT06203275Phase 3
- Concentration-QT Study of Paroxetine in Healthy AdultsCompletedNCT06065735Phase 1Results posted
- Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on VentilationCompletedNCT05470465Phase 1Results posted
- Treatment of Tinnitus With Migraine MedicationsCompletedNCT04404439Phase 4Results posted
- Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican ParticipantsCompletedNCT04311463Phase 1Results posted
- A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and ComorbidityCompletedNCT02655354Not applicableResults posted
- Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal WomenCompletedNCT01829919Phase 1Results posted
- Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI StudyCompletedNCT01748955Phase 4Results posted
- Neural Circuits in Women With Abuse and Posttraumatic Stress DisorderCompletedNCT01681849Phase 4Results posted
- Vilazodone for Treatment of Geriatric DepressionCompletedNCT01608295Phase 4Results posted
- Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)CompletedNCT01361308Phase 3Results posted
- Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive DisorderCompletedNCT01354314Phase 1/2Results posted
- Paxil CR Bioequivalence Study Brazil - Fed AdministrationCompletedNCT01339247Phase 1Results posted
- Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) AttackCompletedNCT01130103Phase 4Results posted
- 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor SymptomsCompletedNCT01101841Phase 3Results posted
- Paroxetine Hydrochloride 40 mg Tablets Under Fasting ConditionsCompletedNCT00841698Phase 1Results posted
- Paroxetine Hydrochloride 40 mg Tablets Under Fed ConditionsCompletedNCT00841659Phase 1Results posted
- Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)TerminatedNCT00812812Phase 4Results posted
- Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With MenopauseCompletedNCT00786188Phase 2Results posted
- Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)CompletedNCT00700999Phase 4Results posted
- Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)CompletedNCT00560612Phase 4Results posted
- Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)TerminatedNCT00557622Phase 2Results posted
- Paroxetine/Bupropion in Suicide Attempters/Ideators With Major DepressionTerminatedNCT00429169Phase 4Results posted
- MDD POC Study GSK372475 Subjects Depressive DiseaseCompletedNCT00420641Phase 2Results posted
- Monoamine Transporters Genotypes: Risk of PTSD and Related ComorbiditiesCompletedNCT00403455Phase 3Results posted
- Naltrexone & SSRI in Alcoholics With Depression/PTSDCompletedNCT00338962Phase 3Results posted
- Paroxetine for Comorbid Social Anxiety Disorder and AlcoholismCompletedNCT00246441Phase 4Results posted
- Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1CompletedNCT00218439Not applicableResults posted
- Study of Antidepressants in Parkinson's DiseaseCompletedNCT00086190Phase 3Results posted
- Treatment of Depression in Parkinson's Disease TrialCompletedNCT00062738Phase 2Results posted
- Management of Acute Tinnitus With Migraine MedicationsActive, not recruitingNCT06799169Phase 4
- Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical MenopauseCompletedNCT06763484Phase 2
- Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy SubjectsCompletedNCT06232109Phase 1
- Paroxetine Safety and Efficacy in Rheumatoid ArthritisCompletedNCT06231745Phase 3
- Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy AdultsCompletedNCT05992428Phase 1
- Effects of Paroxetine on Cardiovascular Function in Septic PatientsCompletedNCT05725837Phase 2
- Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor SymptomsStatus unknownNCT05637671Phase 3
- EEG Results of Deep TMS in Patients With OCDStatus unknownNCT05188833Not applicable
- Effects of SERT Inhibition on the Subjective Response to LSD in Healthy SubjectsCompletedNCT05175430Phase 1
- A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult ParticipantsCompletedNCT04981704Phase 1
- To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy VolunteersCompletedNCT04888728Phase 1
- The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis PatientsWithdrawnNCT04757571Phase 1/2
- Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female SubjectsCompletedNCT04650542Phase 1
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental DisordersCompletedNCT04218981Not applicable
- Transcutaneous Posterior Tibial Nerve Stimulation for Premature EjaculationCompletedNCT04207723Not applicable
- Endobiotics for Phenotyping of Human Cytochrome P450 EnzymesCompletedNCT04188028Not applicable
- Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine TreatmentCompletedNCT03894085Not applicable
- Effect of Tamsulosin on PE Compared With Paroxetine HydrochlorideStatus unknownNCT03879746Phase 3
- Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy VolunteersCompletedNCT03504475Phase 1
- Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety DisordersCompletedNCT03277339Phase 4
- Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial InfarctionCompletedNCT03274752Phase 2
- Hot Flash as a Marker of Cardiovascular Risk in Recent Postmenopause: Effects of Non-hormonal TreatmentsCompletedNCT03149419Phase 4
- Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6CompletedNCT03054220Not applicable
- Long Term Treatment of Panic Disorder With Clonazepam or ParoxetineCompletedNCT02852577Phase 4
- Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy VolunteersCompletedNCT02681198Phase 1
- Newer Antidepressants in Combination With Pregabalin for Fibromyalgia SyndromeCompletedNCT02451475Phase 1/2
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male VolunteersCompletedNCT02264184Phase 1
- Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 GeneStatus unknownNCT02237937Phase 4
- The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled TrialCompletedNCT02191124Phase 4
- A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy SubjectsCompletedNCT02174822Phase 1
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD PatientsCompletedNCT02022709Phase 4
- Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome PatientsWithdrawnNCT01916200Phase 4
- Interaction Between Paroxetine and TelaprevirTerminatedNCT01841502Phase 2
- Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early ImprovementCompletedNCT01458626Phase 4
- Amitriptyline and Paroxetine Treatment of Major DepressionCompletedNCT01049347Phase 3
- Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature EjaculationCompletedNCT01024491Phase 3
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder PatientsTerminatedNCT00926835Phase 4
- Interaction Study of Timolol Eye Drops and Paroxetine CapsulesCompletedNCT00879099Phase 1
- BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress DisorderCompletedNCT00839397Phase 3
- Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic DisorderCompletedNCT00767754Phase 4
- PAXIL CR Bioequivalence StudyCompletedNCT00749359Phase 1
- Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest PainStatus unknownNCT00736346Not applicable
- Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety DisorderCompletedNCT00715039Not applicable
- Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)CompletedNCT00672776Phase 4
- Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)TerminatedNCT00665678Phase 4
- Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedNCT00650403Phase 1
- Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedNCT00648193Early Phase 1
- Early Intervention for Post Traumatic Stress Disorder (PTSD)WithdrawnNCT00641173Not applicable
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderCompletedNCT00629551Phase 3
- Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNCT00610909Phase 4
- Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia SyndromeCompletedNCT00610610Phase 4
- A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual DysphoriaCompletedNCT00516113Phase 4
- Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled ReleaseStatus unknownNCT00492414Phase 4
- Duloxetine Versus Paroxetine for Major DepressionCompletedNCT00489775Phase 3
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic AttacksCompletedNCT00457106Not applicable
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 PathwayCompletedNCT00456898Phase 1
- A Combination Therapy In Patients With Social Anxiety DisorderCompletedNCT00403962Phase 2
- Treatment Of Patients With Social Anxiety DisorderCompletedNCT00397722Phase 2
- Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.CompletedNCT00394056Phase 2
- Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of ParoxetineCompletedNCT00357045Phase 4
- PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety PatientsCompletedNCT00343707Phase 2
- Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance DependenceCompletedNCT00330239Phase 4
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00329147Phase 3
- Social Anxiety Disorder Study Of ParoxetineCompletedNCT00318669Phase 3
- Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic PainCompletedNCT00291148Phase 3
- A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety DisorderCompletedNCT00273039Phase 2
- Long-term Study Of Paroxetine in Women and MenCompletedNCT00264654Phase 3